Scolaris Content Display Scolaris Content Display

First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To evaluate the benefits and harms of drugs inhibiting the RAS in patients with elevated blood pressure (>130/85mmHg).